Characterization of acute and long-term sulfur mustard-induced skin injuries in hairless guinea-pigs using non-invasive methods

Skin Research and Technology

Volumn 16, Issue 1, 2010, Pages 114-124

  Dachir, Shlomit ^a   Cohen, Maayan ^a   Fishbeine, Eliezer ^a   Sahar, Rita ^a   Brandies, Rachel ^a   Horwitz, Vered ^a   Kadar, Tamar ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Hairless guinea pig; MMP; Prostaglandin; Skin; Sulfur mustard

Indexed keywords

ANIMAL MODEL; ANTI-INFLAMMATORIES; AREA MEASUREMENT; BASAL CELLS; BASEMENT MEMBRANE; CLINICAL EVALUATION; CYTOTOXIC EFFECTS; HEALING PROCESS; HEALTH SYSTEMS; HISTOLOGICAL EVALUATION; INFLAMMATORY CELLS; LONG-TERM EFFECTS; METALLOPROTEINASE-9; MMP; NONINVASIVE METHODS; PIG MODEL; POST-EXPOSURE; SKIN EXPOSURE; SKIN INJURIES; SMALL ANIMAL MODEL; SULFUR MUSTARD; TIME DURATION; TRANSEPIDERMAL WATER LOSS;

ANIMALS; BIOLOGICAL RADIATION EFFECTS; DERMATOLOGY; SKIN; SULFUR;

ULSI CIRCUITS;

ADEXONE; DEXAMETHASONE; DICLOFENAC DIETHYLAMINE; GELATINASE B; MUSTARD GAS; PROSTAGLANDIN E; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ERYTHEMA; GUINEA PIG; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; SKIN EDEMA; SKIN TOXICITY; SKIN WATER LOSS; WOUND HEALING;

ACUTE DISEASE; ANIMALS; BIOPSY; BLISTER; CHRONIC DISEASE; DERMATITIS, CONTACT; DERMATOLOGIC AGENTS; DISEASE MODELS, ANIMAL; ERYTHEMA; GUINEA PIGS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MUSTARD GAS; SKIN; SKIN ABSORPTION; WATER;

EID: 73549101718     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.1600-0846.2009.00409.x     Document Type: Article

References (57)

1. Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad of Dermatol 1995, 32:765-776.
2. Balali-Mood M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fund Clin Pharmacol 2005, 19:297-315.
3. Willems JL. Clinical management of mustard gas casualties. Anna Med Militaris 1989, 3((Suppl.)):1-61.
4. Sinclair DC. Disability produced by exposure of skin to mustard-gas vapour. Br Med J 1950, 1:346-349.
5. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003, 45:1136-1143.
6. Balali-Mood M, Hefazi M, Mahmoudi M, Jalali I, Attaran D, Maleki M, Razavi MRE, Zare G, Jaafari MR, Tabatabaee A. Evaluation of delayed toxic effects of sulfur mustard poisoning in severely intoxicated Iranian veterans: a cross-sectional study. ASA Newsletter 2004, 22:17-25.
7. Graham JS, Chilcott RP, Rice P, Milner SM, Hurst CG, Maliner BI. Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J Burns Wounds 2005, 4:e1-e45.
8. Shohrati M, Davoudi SM, Keshavarz S, Sadr B, Tajik A. Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. Cut Ocular Toxicol 2007, 26:249-255.
9. Panahi Y, Davoodi SM, Khalill H, Dashti-Khavidaki S, Bigdeli M. Phenol and menthol in the treatment of chronic skin lesions following mustard gas exposure. Singapore Med J 2007, 48:392-395.
10. Braue EH, Koplovitz I, Mitcheltree LW, Clayson ET, Litchfield MR, Bangledorf CR. Characterization of the sulfur mustard vapor induced cutaneous lesions on hairless guinea pigs. Toxicol Methods 1992, 2:242-254.
11. Brau EH, Nalls CR, Way RA, Zallnick JE, Rieder RG, Mitcheltree LW. The haired guinea pig as a vesicant animal model. Proceedings of the 1996 Medical Defense Bioscience Review 1996, 685-693. In, Maryland, USA, US Army Medical Research and Materiel Command
12. Chauhan RS, Murthy LVR, Arora U, Malhotra PR. Structural changes induced by sulphur mustard in rabbit skin. J Appl Toxicol 1996, 16:491-495.
13. Smith KJ, Casillas RP, Graham J, Skelton HG, Stemler F, Hackley BE. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. Proceedings of the 1996 Medical Defense Bioscience Review 1996, 1071-1077. In, Maryland, USA, US Army Medical Research and Materiel Command
14. Zlotogorski A, Goldenhersh M, Shafran A. A model for quantitative measurement of sulfur mustard skin lesions in the rabbit ear. Toxicology 1997, 120:105-110.
15. Casillas RP, Mitcheltree LW, Stemler FW. The mouse ear model of cutaneous sulfur mustard injury. Toxicol Methods 1997, 7:381-397.
16. Dachir S, Fishbeine E, Meshulam Y, Sahar R, Amir A, Kadar T. Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Hum Exp Toxicol 2002, 21:197-203.
17. Kadar T, Fishbine E, Meshulam J, Sahar R, Amir A, Barness I. A topical skin protectant against chemical warfare agents. IMAJ 2003, 5:1-3.
18. Paromov V, Suntres Z, Smith M, Stone WL. Sulfur mustard toxicity following dermal exposure. J Burns Wounds 2007, 7:60-84.
19. Kadar T, Fishbeine E, Meshulam Y, Sahar R, Chapman S, Liani H, Barness I, Amir A. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model. J Appl Toxicol 2000, 20:S133-S136.
20. Simon GA, Maiback HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations - an overview. Skin Pharmacol Appl Skin Physiol 2000, 13:229-234.
21. Sullivan TP, Eaglstein KWH, Davis SC, Mertz P. The pig as a model for human wound healing. Wound Rep Reg 2001, 9:66-76.
22. Sueki H, Gammal C, Kudoh K, Kligman AM. Hairless guinea pig skin: anatomical basis for studies of cutaneous biology. Eur J Dermatol 2000, 10:357-364.
23. Sueki H, Kligman AM. Cutaneous toxicity of chemical irritants on hairless guinea pigs. J Dermatol 2003, 30:859-870.
24. Fox MA, Mcnichols RJ, Gowda A, Motamedi M. The use of the hairless guinea pig in tattoo research. Contemp Top Lab Anim Sci 2004, 43:35-38.
25. Marlow DD, Mershon MM, Mitcheltree LW, Petrali JP, Jaax GP. Sulfur mustard-induced skin injury in hairless guinea pigs. J Toxicol - Cut Ocular Toxicol 1990, 9:179-192.
26. Mershon MM, Mitcheltree LW, Petrali JP, Braue EH, Wade JV. Hairless guinea pig bioassay model for vesicant vapor exposures. Fund Appl Toxicol 1990, 15:622-630.
27. Petrali JP, Oglesby SB, Hamilton TA, Mills KR. Comparative morphology of sulfur mustard effects in the hairless guinea pig and a human skin equivalent. J Submicrosc Cytol Pathol 1993, 25:113-118.
28. Logan TP, Millard CB, Shutz M, Schulz SM, Lee RB, Bongiovanni R. Cutaneous uptake of 14 C-HD vapor by the hairless guinea pig. Drug Chem Toxicol 1999, 22:375-387.
29. Snider TH, Matthews MC, Braue EH Jr. Model for assessing efficacy of topical skin protectants against sulfur mustard vapor using hairless guinea pigs. J Appl Toxicol 1999, 19:S55-S58.
30. Kan RK, Pleva CM, Hamilton TA, Anderson DR, Petrali JP. Sulfur mustard-induced apoptosis in hairless guinea pig skin. Toxicol Pathol 2003, 31:185-190.
31. Dachir S, Fishbeine E, Meshulam Y, Sahar R, Chapman S, Amir A, Kadar T. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. J Appl Toxicol 2004, 24:107-113.
32. Smith KJ, Graham JS, Skelton HG, O'Leary T, Moeller RB, Okerberg CV, Hurst CG. Evaluation of cross-reacting anti-human antibodies in the euthymic hairless guinea pig model (HGP) suggests that the HGP may be a model for the study of proliferative skin disease. J Dermatol Sci 1997, 14:240-250.
33. Panchagnula R, Stemmer K, Ritsche WA. Animal models for transdermal drug delivery. Meth Find Exp Clin Pharmacol 1997, 19:335-341.
34. Smith KJ, Graham JS, Moeller RB, Okerberg CV, Skelfon H, Hurst CG. Histopathologic features seen in sulfur mustard induced cutaneous lesions in hairless guinea pigs. J Cutan Pathol 1995, 22:260-268.
35. Kim YB, Hur GH, Choi DS, Shin S, Han BG, Lee YS, Sok DE. Effects of calmodulin antagonists and anesthetics on the skin lesions induced by 2-chloroethylethyl sulfide. Eur J Pharmacol 1996, 313:107-114.
36. Sawyer TW, Conley J, Hunter K, Lundy P, Hamilton M. Domestic swine model for the assessment of chemical warfare agent-anesthetic interactions: some effects of sulfur mustard. Mil Med 2000, 165:573-578.
37. Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical defense against mustard gas: toxic mechanisms and pharmacological implications 1991, Boca Raton, FL, CRC Press Inc.
38. Bongiovanni R, Millard CB, Schulz SM, Romano JM. Estimation of neutrophil infiltration into hairless guinea pig skin treated with 2,2′-dichlorodiethyl sulfide. Proceedings of the 1993 Medical Defense Bioscience Review 1993, 89-395. In, Maryland, USA, US Army Medical Research and Materiel Command
39. Graham JS, Schomacker KT, Glatter RD, Briscoe CM, Braue EH, Squibb KS. Bioengineering methods employed in the study of wound healing of sulphur mustard burns. Skin Res Technol 2002, 8:57-69.
40. Petrali JP, Oglesby SB, Hamilton TA, Mills KR. Ultrastructural pathology and immunohistochemistry of mustard gas lesion. Proceedings of the 1993 Medical Defense Bioscience Review 1993, 15-20. In, Maryland, USA, US Army Medical Research and Materiel Command
41. Yourick JJ, Dawson JS, Benton CD, Craig ME, Mitcheltree LW. Pathogenesis of 2,2′-dichlorodiethyl sulfide in hairless guinea pigs. Proceedings of the 1993 Medical Defense Bioscience Review 1993, 21-30. In, Maryland, USA, US Army Medical Research and Materiel Command
42. Givant-Horwitz V, Dachir S, Cohen L, Yoav S, Gutman H, Cohen M, Fishbine E, Turetz J, Kadar T, Amir A. Involvement of MMPs in ocular response to sulfur mustard in rabbits. Israel society for Vision & Eye Research, 27 Annual Meeting, Neve-Ilan 2007
43. Givant-Horwitz V, Amir A, Cohen L. Involvement of matrix metalloproteinases in the cutaneous and ocular response to sulfur mustard. Proceedings of the 2008 Medical Defense Bioscience Review 2008, In, Maryland, USA, US Army Medical Research and Materiel Command, p. 155
44. Sabourin CK, Danne MM, Buxton KL, Casillas RP, Schlager JJ. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 2002, 16:263-272.
45. Shakarjian MP, Bhatt P, Gordon MK. Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure. J Appl Toxicol 2006, 26:239-246.
46. Herouy Y. Matrix metalloproteinases in skin pathology. Int J Mol Med 2001, 7:3-12.
47. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cel Biochem 2003, 253:269-285.
48. Barranco VP. Mustard gas and the dermatologist. Int J Dermatol 1991, 30:684-686.
49. Cowan FM, Broomfield CA. Putative roles of inflammation in the dermatopathology of sulfur mustard. Cell Biol Toxicol 1993, 9:201-213.
50. Arroyo CM, Schafer RJ, Kurt EM, Broomfield CA, Carmichael AJ. Response of normal human keratinocytes to sulfur mustard (HD): cytokine release using a non-enzymatic detachment procedure. Hum Exp Toxicol 1999, 18:1-11.
51. Ricketts KM, Santai CT, France JA, Graziosi AM, Doyel TD, Gazaway MY, Casillas RP. Inflammatory cytokine response in sulfur mustard-exposed mouse skin. J Appl Toxicol 2000, 20:S73-S76.
52. Sabourin CK, Petrali JP, Casillas RP. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin. J Biochem Mol Toxicol 2000, 14:291-302.
53. Yourick JJ, Dawson JS, Mitcheltree LW. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. J Appl Toxicol 1995, 15:133-138.
54. Casillas RP, Kiser RC, Truxall JA, Singer AIW, Shumaker SM, Niemuth NA, Ricketts KM, Mitcheltree LW, Castrejo LR, Blank JA. Therapeutic approaches to dermatotoxicity by sulfur mustard I. Modulation of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J Appl Toxicol 2000, 20:S145-S151.
55. Babin MC, Ricketts K, Skvorak JP, Gazaway M, Mitcheltree LW, Casillas RP. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEMV). J Appl Toxicol 2000, 20:S141-S144.
56. Vogt RF, Dannenberg AM, Schofield BH, Hynes NA, Papirmeister B. Pathogenesis of skin lesions caused by sulfur mustard. Fund Appl Toxicol 1984, 4:S71-S83.
57. Dachir S, Fishbine E, Sahar R, Meshulam J, Cohen L, Kadar T. Post-exposure anti-inflammatory treatment against cutaneous HD injury in pigs. Proceedings of the 2002 Medical Defense Bioscience Review 2002, 998-1007. In, Maryland, USA, US Army Medical Research and Materiel Command